Combinatorial and fragment-based in silico design of PI3K-alpha natural hybrid antagonists for breast cancer therapeutics

Aim: The PI3K (phosphoinositide 3-kinase)-alpha isoform is found upregulated in 30–40% of breast cancer. Currently, there are limited selective and specific drugs that target PI3K-alpha, and no natural therapeutic option is available. This study aims to develop natural hybrid antagonists of PI3K-alp...

Full description

Saved in:
Bibliographic Details
Main Authors: Navya Aggarwal, Shinjini Sen, Banashree Bondhopadhyay
Format: Article
Language:English
Published: Open Exploration 2025-04-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A1008108/1008108.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!